L4. Eosinophils: How they contribute to endothelial damage and dysfunction
Université Libre de Bruxelles, hôpital Erasme, département de médecine interne, Brussels, Belgium. Electronic address: .La Presse Médicale (Impact Factor: 1.08). 02/2013; 42(4). DOI: 10.1016/j.lpm.2013.01.005
- [Show abstract] [Hide abstract]
ABSTRACT: The symptomatic hypereosinophilic patient must be approached in a stepwise manner, with thorough assessment to determine whether the hypereosinophilia itself is contributing to damage and disease manifestations (thereby defining a hypereosinophilic syndrome), and to identify an eventual cause of hypereosinophilia, followed by initiation of treatment directed against the underlying condition or deleterious hypereosinophilic state. Situations encountered in the clinic are extremely heterogeneous because of the numerous potential causes of hypereosinophilia and the variable spectrum of eosinophil-mediated organ damage. A practical approach to many of these situations is presented in this review. Copyright © 2015 Elsevier Inc. All rights reserved.Immunology and allergy clinics of North America 08/2015; 35(3):561-575. DOI:10.1016/j.iac.2015.05.006 · 1.82 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.